Weight loss injections and levothyroxine: what the evidence says

What the prescribing guidance actually says about GLP-1 medicines and absorption

The Summary of Product Characteristics (SmPC) for tirzepatide, available via the eMC, notes that because tirzepatide delays gastric emptying it has the potential to slow the absorption of any orally taken medicine. The same is documented for semaglutide. Neither SmPC lists levothyroxine as a named contraindication, but the general absorption caution applies to it directly.

Levothyroxine sits in a category of medicines where absorption variation genuinely matters. The difference between 80% and 90% absorption of a daily 100-microgram dose sounds small, but over weeks it can shift TSH outside the therapeutic range. That is why pharmacists already advise taking levothyroxine first thing, at least half an hour before breakfast or other medicines. If GLP-1 treatment slows food transit further, that established timing window becomes harder to rely on.

The practical upshot is not that the two medicines cannot be taken together (the clinical consensus supports concurrent use) but that your TSH should be checked a few weeks after starting or after each dose increase. Your GP or endocrinologist is the right person to arrange that, and your prescriber at nume will notify your GP as part of standard practice, in line with GPhC guidance.

For a broader overview of which health conditions and medicines interact with weight loss injections, the general interactions guide covers the landscape in more detail.

Thyroid history that changes the picture entirely

There is one thyroid-related situation where GLP-1 medicines are not appropriate at all. Anyone with a personal or family history of medullary thyroid carcinoma (MTC), or with Multiple Endocrine Neoplasia type 2 (MEN2), should not use tirzepatide or semaglutide. This is a hard contraindication in both products' prescribing information, based on findings in rodent studies where GLP-1 receptor agonists were linked to thyroid C-cell tumours at high doses. The relevance to humans at clinical doses remains uncertain, but the precaution stands.

Hypothyroidism managed with levothyroxine is a completely different condition (it involves the thyroid's hormone output, not C-cell proliferation) and it does not fall under this contraindication. Still, you should mention your thyroid diagnosis, your levothyroxine dose, and any family history of thyroid cancer during your consultation. A prescriber assessing you for a GLP-1 injection needs the whole picture. The eligibility criteria for weight loss injections explains what a prescriber weighs up more broadly.

People with an underactive thyroid considering weight loss injections sometimes wonder whether hypothyroidism itself affects eligibility, the short answer is that it counts as a weight-related comorbidity, which can actually support a clinical case for treatment at a lower BMI threshold.

Monitoring levothyroxine once GLP-1 treatment begins

The NHS patient information on tirzepatide advises telling your doctor or pharmacist about all medicines you take before starting treatment. For levothyroxine specifically, this matters on a practical level: if your TSH drifts during the first few months of GLP-1 treatment, your prescriber needs a baseline to compare it against.

One habit worth building immediately: check the timing of your levothyroxine dose on the day you give yourself each weekly injection. Levothyroxine should still go first, on an empty stomach, well before any food or other medicines. Keeping that routine consistent (same time, same gap) reduces one variable from the equation.

Significant weight loss itself can also change levothyroxine requirements. As body weight falls, the dose that was correct at a higher weight may become relatively high, and symptoms of over-replacement (palpitations, poor sleep, feeling shaky) are worth reporting. None of this makes GLP-1 injections unsuitable; it makes regular thyroid function tests a sensible part of your care plan. Your GP can arrange these, and if you want to understand the weekly injection schedule alongside your existing medication routine, that page explains the dosing rhythm. People taking other daily medicines alongside GLP-1 therapy sometimes find it helpful to read about how concurrent medicines are managed generally, since the timing-and-absorption logic overlaps. Thinking about starting? Getting a weight loss injection prescription outlines the private route from consultation to delivery.

If you are ready to discuss your specific medication history with a clinician, check your eligibility with our prescribers, consultations are free, reviewed the same day, and include a full medicines review before anything is approved.